Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03210402 · ClinicalTrials.gov registry record · NA
REmodeling the Left Ventricle With Atrial Modulated Pacing
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03210402 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 22 participants.
The verdict
NCT03210402, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
New therapy tested in heart failure with preserved ejection fraction (HFpEF) patients with approved indications for pacing to determine if elevated pacing therapy is tolerated and whether there is a signal for efficacy.
Interventions
- DEVICE Elevated night pacing on
- DEVICE Elevated night pacing off
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2021-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03210402
The ClinicalTrials.gov registry entry for NCT03210402 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Elevated night pacing on is the first listed.
NCT03210402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03210402 about?
NCT03210402 is a clinical study titled "REmodeling the Left Ventricle With Atrial Modulated Pacing". New therapy tested in heart failure with preserved ejection fraction (HFpEF) patients with approved indications for pacing to determine if elevated pacing therapy is tolerated and whether there is a signal for efficacy.
What is the current status of trial NCT03210402?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-09-15. Estimated completion is 2021-03-15.
What interventions are being tested in trial NCT03210402?
The interventions under investigation include: Elevated night pacing on (DEVICE), Elevated night pacing off (DEVICE).
Who is sponsoring clinical trial NCT03210402?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.